https://de.marketscreener.com/kurs/aktie/ARROWHEAD-PHARMACEUTICALS-26864651/news/Arrowhead-Pharmaceuticals-Inc-initiiert-Expanded-Access-Programm-fur-Plozasiran-46281388/?utm_source=telegram&utm_medium=social&utm_campaign=share